Core Insights - Beta Bionics, Inc. plans to release its third quarter 2025 financial results on October 28, 2025, after market close [1] - A conference call and webcast will be held on the same day at 4:30 pm Eastern Time [1] Company Overview - Beta Bionics is a commercial-stage medical device company focused on developing innovative solutions for insulin-requiring individuals with diabetes [2] - The company utilizes advanced adaptive closed-loop algorithms to enhance diabetes treatment [2] - The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines insulin doses, aiming to improve health outcomes for a wide range of diabetes patients [2]